Rakuten Investment Management Inc. Trims Stock Holdings in Cencora, Inc. $COR

Rakuten Investment Management Inc. trimmed its holdings in Cencora, Inc. (NYSE:COR) by 54.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 25,094 shares of the company’s stock after selling 30,348 shares during the quarter. Rakuten Investment Management Inc.’s holdings in Cencora were worth $8,538,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently modified their holdings of COR. United Bank raised its holdings in shares of Cencora by 4.5% in the second quarter. United Bank now owns 7,032 shares of the company’s stock worth $2,109,000 after buying an additional 305 shares during the period. Nebula Research & Development LLC purchased a new stake in shares of Cencora in the second quarter worth approximately $595,000. Treasurer of the State of North Carolina raised its holdings in shares of Cencora by 7.9% in the second quarter. Treasurer of the State of North Carolina now owns 85,534 shares of the company’s stock worth $25,647,000 after buying an additional 6,244 shares during the period. Diversify Advisory Services LLC raised its holdings in shares of Cencora by 94.1% in the second quarter. Diversify Advisory Services LLC now owns 2,585 shares of the company’s stock worth $747,000 after buying an additional 1,253 shares during the period. Finally, DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main raised its holdings in shares of Cencora by 26.0% in the second quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main now owns 73,452 shares of the company’s stock worth $22,025,000 after buying an additional 15,154 shares during the period. 97.52% of the stock is currently owned by hedge funds and other institutional investors.

Cencora Stock Down 0.1%

Shares of NYSE COR opened at $281.22 on Wednesday. The company has a current ratio of 0.95, a quick ratio of 0.59 and a debt-to-equity ratio of 3.40. The stock has a market capitalization of $54.71 billion, a PE ratio of 21.57, a price-to-earnings-growth ratio of 1.52 and a beta of 0.59. The stock’s fifty day simple moving average is $287.49 and its two-hundred day simple moving average is $326.05. Cencora, Inc. has a 12-month low of $244.82 and a 12-month high of $377.54.

Cencora (NYSE:COR) last announced its earnings results on Wednesday, May 6th. The company reported $4.75 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.82 by ($0.07). The company had revenue of $78.36 billion for the quarter, compared to the consensus estimate of $81.09 billion. Cencora had a net margin of 0.78% and a return on equity of 135.20%. The firm’s revenue was up 3.9% compared to the same quarter last year. During the same period last year, the business posted $4.42 EPS. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. As a group, analysts expect that Cencora, Inc. will post 17.79 EPS for the current fiscal year.

Cencora Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Monday, June 1st. Shareholders of record on Friday, May 15th were given a dividend of $0.60 per share. This represents a $2.40 annualized dividend and a yield of 0.9%. The ex-dividend date of this dividend was Friday, May 15th. Cencora’s dividend payout ratio (DPR) is 18.40%.

Cencora announced that its Board of Directors has initiated a stock repurchase plan on Thursday, May 21st that authorizes the company to buyback $2.00 billion in outstanding shares. This buyback authorization authorizes the company to reacquire up to 3.9% of its shares through open market purchases. Shares buyback plans are often a sign that the company’s management believes its shares are undervalued.

Wall Street Analyst Weigh In

Several brokerages have recently weighed in on COR. Weiss Ratings downgraded Cencora from a “buy (b)” rating to a “buy (b-)” rating in a report on Friday, May 22nd. Robert W. Baird dropped their price objective on Cencora from $420.00 to $339.00 and set an “outperform” rating on the stock in a research note on Thursday, May 7th. Evercore set a $360.00 price objective on Cencora in a research note on Wednesday, April 8th. Morgan Stanley set a $342.00 price objective on Cencora in a research note on Friday, May 8th. Finally, William Blair started coverage on Cencora in a research note on Tuesday, April 28th. They issued a “market perform” rating on the stock. Twelve analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $374.00.

About Cencora

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.